| Page 11 | Cafepharma

You are here

Primary tabs

Additional Results from Phase I Study Show Inovio's INO-5150 Stabilizing Effect on Prostate Cancer

Post date: May 18, 2018 - 9:35am

Precision Cancer Company Accent Therapeutics Launches with $40 Million Series A Round

Post date: May 18, 2018 - 9:24am

BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer

Post date: May 17, 2018 - 9:53am

Intellia Therapeutics Announces WT1 for treating Acute Myeloid Leukemia as Its First Cell Therapy Target

Post date: May 17, 2018 - 9:35am

Exelixis and Ipsen Announce European Approval of Cabometyx for Previously Untreated Intermediate- or Poor-Risk Advanced Renal Cell Carcinoma

Post date: May 17, 2018 - 9:17am

Pfizer's LYRICA Meets Primary Endpoint in Phase III Trial in Pediatric Epilepsy

Post date: May 17, 2018 - 9:00am

FDA Accepts Turnstone Biologics' IND for Immunotherapy Targeting HPV Positive Cancers

Post date: May 16, 2018 - 8:28am

BioLineRx Receives European Patent Covering BL-8040 with Cytarabine for Acute Myeloid Leukemia

Post date: May 16, 2018 - 8:25am

EIP Pharma Receives $20.5 Million Series B to Fund Alzheimer's Candidate

Post date: May 16, 2018 - 7:55am

Indivior Reaches Patent Infringement Settlement With Par Pharmaceutical Over Suboxone

Post date: May 15, 2018 - 9:36am

Pages